MSB 1.03% 98.0¢ mesoblast limited

Back pain read out - what are your thoughts?, page-10

  1. 942 Posts.
    lightbulb Created with Sketch. 298
    There is no doubt at all that MSB will need another P3 trial before approval will be granted by the FDA.

    Mesoblast has mentioned in the past that their partner, Grunenthal, will run another P3 in Europe, conditional on a positive result of our current trial.

    The results of that trial are years away, but if positive, would likely see approval in both Europe and the US.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.